Last Updated:

Friday, February 3, 2023

5:55 AM

Germany

BioNTech

BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.

BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.

Newsroom